SCHEMBL3307343

SCHEMBL3307343

O=C(O)/C(O)=C\C(=O)c1ncccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.39
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
LMNA P02545 3/20 0.34
NAPRT Q6XQN6 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
P4HTM Q9NXG6 1/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 2/20 0.34
PKM P14618 2/20 0.34
RAB9A P51151 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.32
AGER Q15109 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3307346 1.00 P2RX7 (0.39) P2RX7CTNNB1WNT3ALMNANAPRT
SCHEMBL3307340 1.00 P2RX7 (0.39) P2RX7CTNNB1WNT3ALMNANAPRT
SCHEMBL3309986 0.79 P2RX7 (0.37) P2RX7CTNNB1WNT3ALMNAL3MBTL1
SCHEMBL3309984 0.79 P2RX7 (0.37) P2RX7CTNNB1WNT3ALMNAL3MBTL1
SCHEMBL3310899 0.76 MAPT (0.57) LMNANAPRTL3MBTL1P4HTMKDM4E
SCHEMBL3310895 0.76 MAPT (0.57) LMNANAPRTL3MBTL1P4HTMKDM4E
SCHEMBL13424977 0.76 P2RX7 (0.34) P2RX7CTNNB1WNT3ALMNANAPRT
SCHEMBL3310903 0.76 MAPT (0.57) LMNANAPRTL3MBTL1P4HTMKDM4E
SCHEMBL2320853 0.72 P2RX7 (0.44) P2RX7CTNNB1WNT3ALMNANAPRT
SCHEMBL31141952 0.70 AKT1 (0.44) P2RX7CTNNB1WNT3ALMNANAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 P2RX7 4627/4885CTNNB1 4484/4885WNT3A 3622/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 P2RX7 4627/4885CTNNB1 4484/4885WNT3A 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.